Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Jeffrey S. Stroup

doi:10.2337/db07-0082

Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Jeffrey S. Stroup

Administration and Leadership

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e1
Journal	Diabetes
Volume	56
Issue number	5
DOIs	https://doi.org/10.2337/db07-0082
State	Published - May 2007

Access to Document

10.2337/db07-0082

Cite this

@article{455e4361868c429abe74da1d4f47f46e,

title = "Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]",

author = "Stroup, {Jeffrey S.}",

year = "2007",

month = may,

doi = "10.2337/db07-0082",

language = "English",

volume = "56",

pages = "e1",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

number = "5",

}

TY - JOUR

T1 - Comment on

T2 - Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

AU - Stroup, Jeffrey S.

PY - 2007/5

Y1 - 2007/5

UR - http://www.scopus.com/inward/record.url?scp=34248212236&partnerID=8YFLogxK

U2 - 10.2337/db07-0082

DO - 10.2337/db07-0082

M3 - Letter

C2 - 17470558

AN - SCOPUS:34248212236

SN - 0012-1797

VL - 56

SP - e1

JO - Diabetes

JF - Diabetes

IS - 5

ER -

Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Access to Document

Other files and links

Cite this